WallStreetZenWallStreetZen

NASDAQ: BRTX
Biorestorative Therapies Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BRTX past revenue growth

How has BRTX's revenue growth performed historically?
Company
108.79%
Industry
63.2%
Market
21.77%
BRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BRTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BRTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BRTX earnings and revenue history

Current Revenue
$121.1k
Current Earnings
-$34.6M
Current Profit Margin
-28,530.4%

BRTX Return on Equity

Current Company
-178.7%
Current Industry
-9.8%
Current Market
-9.5%
BRTX's Return on Equity (-178.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BRTX announces earnings.

BRTX Return on Assets

Current Company
-171.2%
Current Industry
0.6%
BRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BRTX Return on Capital Employed

Current Company
-198.99%
Current Industry
11.2%
BRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BRTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BRTX$121.10k-$34.01M-$34.55M+19.80%N/A
IMRN$770.95k-$2.08M-$2.08M-9.84%N/A
NAVB$115.39k-$14.28M-$17.38M-45.71%N/A
LIXT$0.00-$6.70M-$6.71MN/AN/A
PYPD$0.00-$46.06M-$47.16MN/AN/A
View Top Biotech Stocks

Biorestorative Therapies Earnings & Revenue FAQ

What were BRTX's earnings last quarter?

On Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q3 2022 earnings per share (EPS) of -$1.28, up 74.35% year over year. Total Biorestorative Therapies earnings for the quarter were -$4.66 million. In the same quarter last year, Biorestorative Therapies's earnings per share (EPS) was -$4.99.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

What was BRTX's earnings growth in the past year?

As of Q1 2023, Biorestorative Therapies's earnings has grown year over year. Biorestorative Therapies's earnings in the past year totalled -$34.55 million.

What was BRTX's revenue last quarter?

On Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q3 2022 revenue of $29.00 thousand up 262.5% year over year. In the same quarter last year, Biorestorative Therapies's revenue was $8.00 thousand.

What was BRTX's revenue growth in the past year?

As of Q1 2023, Biorestorative Therapies's revenue has grown 108.79% year over year. This is 45.59 percentage points higher than the US Biotechnology industry revenue growth rate of 63.2%. Biorestorative Therapies's revenue in the past year totalled $121.10 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.